AREG, a ligand of epidermal growth factor receptor (EGFR), is abnormally expressed in multiple types of cancers, such as pancreatic cancer, implicated in mediating the motility, metastasis, and proliferation of tumor cells (Liu et al., 2021). Here, AREG is linked to neoplasm.